What Are the Common Side Effects of Qelbree in Children?
Qelbree (trileptal), approved for the treatment of ADHD in children aged 6 to 12, can cause several side effects. The most frequently reported adverse reactions include somnolence (drowsiness) and vomiting [1].
What Are the Less Common, But More Serious, Side Effects of Qelbree?
While less common, more serious side effects associated with Qelbree use in children include a risk of suicidal thoughts and behaviors. Patients of all ages taking Qelbree should be monitored for new or worsening depression, suicidal thoughts or behavior, and unusual changes in mood or behavior. Additionally, Qelbree carries a risk of serious skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Symptoms to watch for include fever, rash, blistering, and peeling skin [1].
Why is Qelbree Associated with Drowsiness?
Qelbree is known to cause somnolence, or drowsiness, in pediatric patients. This effect is a common side effect of the medication and should be discussed with a healthcare provider if it becomes problematic for the child [1].
What Should Parents Watch For Regarding Qelbree Side Effects?
Parents and caregivers should be vigilant in observing children taking Qelbree for any new or worsening symptoms of depression or suicidal ideation. Changes in mood or behavior, such as increased irritability, agitation, or unusual withdrawal, also warrant immediate medical attention. Any signs of a severe rash, blistering, or peeling skin should be reported to a doctor without delay due to the risk of serious skin reactions [1].
How Does Qelbree Work to Treat ADHD?
Qelbree is a novel treatment for ADHD that works differently from traditional stimulant medications. Its precise mechanism of action is not fully understood, but it is believed to modulate voltage-gated sodium channels and work as a selective norepinephrine reuptake inhibitor (SNRI) [1].
What is the Difference Between Qelbree and Other ADHD Medications?
Qelbree is a non-stimulant medication for ADHD. Unlike stimulant medications, it does not have a potential for abuse or dependence. Its novel mechanism of action targeting norepinephrine is distinct from many other ADHD treatments [1].
---
Sources:
1. https://www.drugpatentwatch.com/